Pharmacologic Interventions for Healthy Pregnancies
This program is being offered live across California in the 7 counties with the highest rates of preterm birth:
- Kern County on March 9, 2019
- Fresno County on March 10, 2019
- Los Angeles County on April 6, 2019
- Sacramento County on February 9, 2019, co-hosted by California Northstate University, Sacramento Valley Pharmacists Association and CSHP Sacramento Valley
- San Bernardino County on January 19, 2019
- Santa Clara County on November 17, 2018, co-hosted by the Golden Gate Society of Health-System Pharmacists, Quatra County Society of Health-System Pharmacists and the Peninsula Pharmacists Association
- San Diego County on October 13, 2018, co-hosted by the San Diego County Pharmacists Association
This course has been developed to promote pharmacist roles in addressing gaps in care during pregnancy and between pregnancies. This course is intended for pharmacists who practice in a variety of settings — including, but not limited to, community pharmacy, specialty pharmacy, ambulatory care. This course will take approximately three hours to complete, including the pre-course assessment, course, post-course assessment, and evaluation — all online. Since the course is available online and on-demand, you are encouraged to complete it at your own pace. Three continuing education hours will be awarded upon course completion. Please note: This course is CAPE-accredited and not ACPE-accredited.
Course Fee & Funding Partners
There is no fee for this course. The course is funded by a Community Grant from the March of Dimes with support of Anthem Blue Cross Foundation.
Upon completing this course, the participant will be able to:
- Identify a woman who is an appropriate candidate for prevention of preterm labor with 17-alpha-hydroxyprogesterone (17OHP), including assessment of clinical indication and gestational age.
- Describe the FDA’s position regarding the use of compounded 17OHP in clinical practice today.
- Assess a specific patient and identify factors which may delay 17OHP acquisition.
Describe preeclampsia and its impact in term and preterm patients.
Identify when a patient meets diagnosis criteria for preeclampsia.
Explain the management of preeclampsia and hypertension in preeclampsia.
Develop a plan to prevent preeclampsia in high risk pregnant patients.
Explain healthy birth spacing and why it’s important.
- List the birth control options to achieve healthy birth spacing.
- Describe considerations for birth control use in the postpartum period.
Clinical Assistant Professor & Clinical Pharmacist, University of Georgia College of Pharmacy
- Consultant, Birth Control Pharmacist
- Clinical Professor, Department of Reproductive Medicine, Division of Maternal Fetal Medicine, UC San Diego
- Pharmacist Specialist, UC San Diego Health
- Assistant Clinical Professor, UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences (w/s)
- Founder and Advanced Practice Pharmacist, The Pharmacists Clinic
- Founder and Consultant, Birth Control Pharmacist
Kristin Harter, PharmD
- Women’s Health Clinical Pharmacist, Zuckerberg San Francisco General Hospital and Trauma Center
- Assistant Clinical Professor, UCSF School of Pharmacy
Alicia Forinash, PharmD, FCCP, BCPS, BCACP
- Professor of Pharmacy Practice, St Louis College of Pharmacy
- Clinical Pharmacy Specialist at the Maternal Fetal Care Center and Women and Infant Substance Help (WISH) Center, SSM Health St. Mary’s
Shareen El-Ibiary, PharmD, FCCP, BCPS
- Professor and Chair, Department of Pharmacy Practice, Midwestern University College of Pharmacy-Glendale
- Consultant, Birth Control Pharmacist
Completing the Course
Please follow the button below to start the course. You will complete the pre-course assessment and then you will be taken to the program videos and materials.
University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (#209) is accredited by the California Accreditation of Pharmacy Education (CAPE) as a recognized provider of continuing pharmacy education. The course expiration date is October 29, 2021.
The California State Board of Pharmacy recognizes CAPE accredited program units for pharmacist license renewal. If you hold a license from another state, please check with that state’s board of pharmacy for eligibility of CAPE units.
Please allow 30 days for the continuing education certificate to be emailed to you following course completion.